hologic inc holx stock rose nearly 3 in the extended session wednesday after the medical technology company reported quarterly earnings and sales that topped wall street views and raised its outlook for fiscal 2023 hologic earned 1874 million or 75 cents a share compared with 4992 million or 195 a share in the yearago period adjusted for onetime items hologic earned 107 a share revenue fell 27 to 107 billion mostly thanks to lower sales of covid19 assays and supplychain “challenges” with semiconductor chips used in the company’s breasthealth business it said analysts polled by factset expected hologic to report adjusted earnings of 91 cents a share on revenue of 1 billion in the quarter “we had a strong start to our fiscal year with doubledigit organic revenue growth ex covid19 in our diagnostics and surgical businesses as well as encouraging signs of recovery in our breast health business” chief executive steve macmillan said in a statement hologic upped its fiscal 2023 revenue guidance to between 385 billion and 4 billion compared with a previous guidance of revenue between 37 billion and 39 billion it raised adjusted eps guidance to between 355 and 385 from an earlier outlook of adjusted eps between 330 and 360 that highlights “the confidence we have in our businesses despite an uncertain macro environment” macmillan said shares of hologic ended the regular trading day up 17